Brean Capital Downgrades Endocyte To Hold By: Benzinga via Benzinga September 30, 2014 at 08:34 AM EDT Analysts at Brean Capital downgraded Endocyte (NASDAQ: ECYT) from Buy to Hold. Endocyte shares have dropped 49.27% over the past 52 ... Read More >> Related Stocks: Endocyte Inc